SCHEMBL16840355

SCHEMBL16840355

COP(Cl)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263974 0.70
SCHEMBL1763099 0.70
SCHEMBL9641707 0.67
SCHEMBL12361939 0.67
SCHEMBL2220875 0.67
SCHEMBL11804125 0.64
SCHEMBL10722422 0.64
SCHEMBL11470966 0.64
SCHEMBL4914424 0.64
SCHEMBL1567412 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016205739-A1 BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT MEKONNEN BELEW (US) 2016-12-22 WO disclosed
WO-2015095783-A1 BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT AGENEBIO, INC. (US) 2015-06-25 WO disclosed